Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HT-2157 in Healthy Volunteers and Major Depressive Disorder
NCT01413932Phase 2Completed
- Sponsor
- Dart NeuroScience LLC
- Start
- Jul 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HT-2157 in major depressive disorder (MDD), sponsored by Dart NeuroScience LLC. Started Jul 2011; status: completed.
02
Drugs
HT-2157
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01413932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413932.